article · Preventive Medicine Reports
Background Lower-income countries are increasingly expected to finance immunisation programmes as global health financing shifts from donor support to domestic ownership, in line with Immunisation Agenda 2030. While rising domestic investment signals progress, concerns remain regarding whether countries have sufficient fiscal space and institutional capacity to sustain immunisation gains independently. Approach This commentary synthesizes evidence from Gavi-supported and transitioning countries to assess readiness for donor transition. It examines financial, economic, and health system factors influencing the sustainability of immunisation programmes. Main findings Three interlocking risks are identified: limited fiscal space, rising vaccine and delivery costs, and macroeconomic instability linked to overlapping aid transitions. Persistent institutional weaknesses in procurement, budgeting, regulatory systems, and supply chain management further threaten sustainability. Evidence from past transitions shows mixed outcomes, with success associated with early financial planning, strong prioritisation of immunisation, and integration into national health systems. Conclusions Although increased domestic investment is essential for country ownership, many lower-income countries are not yet fully prepared to sustain immunisation gains independently. A phased, risk-sensitive transition combining strengthened domestic financing with continued targeted global support is necessary to prevent reversals in coverage and equity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.pmedr.2026.103560
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.